Meeting Prep: Weekly ELT Meeting

Date: Monday, February 9, 2026, 10:00 AM ET Duration: Recurring weekly

External Attendees

Role: VP Commercial Product, Ada Health (ext.ada.com = external/contractor domain)
Focus: Commercial product strategy for life sciences, med tech, pharma partnerships
Key context: Leads DTC Clinical AI initiatives for patient identification and diagnosis acceleration
Recent activity:

- HLTH Community panel (Sep 2025): "The Value Add of Digital Health in Pharma"

- Reuters Pharma USA (Mar 2025): Commercial Product Lead at Booth #55

- Pharma Commercial Excellence Summit (Apr 2025, Madrid): Panel on AI in Launch Excellence

Relevance to Patient Finder: Directly owns commercial product -- key internal stakeholder for Patient Finder product positioning and pharma partner conversations
Copper/CRM: No specific deals found under his name
Open commitments: None tracked

Entity: JMS Capital Limited, UK company (reg. 06924164), incorporated June 2009
Director: Jonathan Mark Schneider (appointed June 2009, 75%+ ownership)
Location: Mill Hill, London, NW7 2DQ
Nature: SIC 96090 (Other service activities n.e.c.)
Possible connection: Could be an investor, advisor, or board-related contact. The email domain suggests a personal/advisory firm rather than institutional investor.
Note: There is also a US-based JMS Capital Inc. focused on healthcare/tech/clean-tech venture -- may be the same Jonathan Schneider with a US entity.
Copper/CRM: No deals found
Open commitments: None tracked

Clarify JMS Capital attendee's role -- advisor? investor? If unknown, ask EA or check board materials.
Randal Whitmore is internal (VP Commercial Product) -- no special prep needed beyond standard ELT agenda.
For the Shireen deck session: check if materials were shared in advance (Drive/email).